Norbert Heinrich - Concepedia

Author

Norbert Heinrich

Ludwig-Maximilians-Universität München ORCID

Also Known As

H Heinrich, Heinrich, Martin Boeree, N Heinrich, N. E. Ntingiya, N. Heinrich, Nobert Heinrich, Norbert Heinrich, Patricia Manjate

134

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München German Center for Infection Research Radboud University Medical Center Radboud University Nijmegen University of St Andrews

About

Norbert Heinrich is an author at Ludwig-Maximilians-Universität München specializing in medicine, tuberculosis, and tuberculosis diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	397
2	Health Sciences	3	3	157
3	Engineering	2	2	37
4	Public Health	2	2	144
5	Epidemiology	2	2	126

Norbert Heinrich

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial Martin J. Boeree, Norbert Heinrich, Rob E. Aarnoutse, The Lancet Infectious Diseases	2016	379
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis Martin J. Boeree, Andreas H. Diacon, Rodney Dawson, American Journal of Respiratory and Critical Care Medicine	2015	310
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment Sven O. Friedrich, Andrea Rachow, Elmar Saathoff, The Lancet Respiratory Medicine	2013	187
Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study Andrea Rachow, Alimuddin Zumla, Norbert Heinrich, PLoS ONE	2011	161
Increased and Expedited Case Detection by Xpert MTB/RIF Assay in Childhood Tuberculosis: A Prospective Cohort Study Andrea Rachow, Petra Clowes, Elmar Saathoff, Clinical Infectious Diseases	2012	142
Evaluation of Tuberculosis Diagnostics in Children: 2. Methodological Issues for Conducting and Reporting Research Evaluations of Tuberculosis Diagnostics for Intrathoracic Tuberculosis in Children. Consensus From an Expert Panela Luís E. Cuevas, Renee Browning, Patrick Bossuyt, The Journal of Infectious Diseases Tuberculosis PreventionDiagnosisPediatric Lung DiseaseDiagnosticsMedical Diagnosis	2012	113
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis Elin M. Svensson, Robin J. Svensson, Lindsey H. M. te Brake, Clinical Infectious Diseases	2018	100
Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus Sabine Dittrich, Birkneh Tilahun Tadesse, Francis Moussy, PLoS ONE Drug ResistanceAntimicrobial StewardshipDiagnostic AssayHealthcare-associated InfectionInfection Control	2016	95
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients Norbert Heinrich, Rodney Dawson, Jeannine du Bois, Journal of Antimicrobial Chemotherapy	2015	91
High Seroprevalence of Rift Valley Fever and Evidence for Endemic Circulation in Mbeya Region, Tanzania, in a Cross-Sectional Study Norbert Heinrich, Elmar Saathoff, Nina Weller, PLoS neglected tropical diseases	2012	87

Page 1